期刊文献+

白血病染色体研究:新发现与新进展 被引量:3

原文传递
导出
摘要 白血病是获得性造血干细胞突变所致的克隆性疾病。染色体分析可以揭示作为恶性克隆标记的遗传学改变,因而受到重视,近年来,随着观察的深入和技术的进步,白血病的染色体研究又取得了重要进展。显带核型分析已成为白血病诊断的常规手段之一。分子一细胞遗传学新技术-荧光原位杂交(PISH)正作为前者的重要补充而得到广泛应用。现将白血病染色体研究的新发现和检测技术的新进展介绍如下。
作者 薛永权
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第8期508-511,共4页 National Medical Journal of China
  • 相关文献

参考文献17

  • 1Advani AS, Pendergast AM. Bcr-Abl variants: biological and clinical aspects. Leuk Res ,2002,26 : 713-720.
  • 2Sinclair PB, Nacheva EP, Leversha M, et al. Large deletions at the t (9;22) breakpoint are common and may identify a poorprognosis subgroup of patients with chronic myeloid leukemia.Blood,2000, 95: 738-743.
  • 3吴炜,薛永权,吴亚芳,潘金兰,沈娟.Ph染色体阳性慢性粒细胞白血病衍生9号染色体缺失的FISH研究[J].中华血液学杂志,2006,27(3):183-186. 被引量:12
  • 4Gozzetti A, Crupi R, Tozzuoli D. The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL).Hematology ,2004,9 : 11-15.
  • 5Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood ,2006, 107 : 742-751.
  • 6Gotlib J, Cools J, Malone JM, et al. The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome' and chronic eosinophilic leukemia: implications for diagnosis, classification,and management. Blood, 2004, 103 : 2879-2891.
  • 7Harris NL, Jaffe ES, Diebold J, et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol,1999, 17:3835-3849.
  • 8Romana SP, Radford-Weiss I, Abdelali RB, et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia,2006, 20 : 696-706.
  • 9Gu BW, Wang Q, Wang JM, et al. Major form of NUP98/HOXC11 fusion in adult AML with t (11; 12)(p15; q13) translocation exhibits aberrant trans-regulatory activity. Leukemia,2003 , 17 : 1858-1864.
  • 10Taki T, Taniwaki M. Chromosomal translocations in cancer and their relevance for therapy. Current Opinion in Oncology,2006,18 :62-68.

二级参考文献8

  • 1Sinclair PB,Nacheva EP,Laversha M,et al.Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukaemia.Blood,2000,95:738-743.
  • 2Cohen N,Rozenfeld-Granot G,Hardan I,et al.Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene:expression profiling,resistance to interferon therapy,and poor prognosis.Cancer Genet Cytogenet ,2001,128:114-119.
  • 3Huntly B J,Reid A,Bench A,et al.Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic factor in chronic myeloid leukaemia.Blood,2001,98:1732-1738.
  • 4Kolomietz E,Al-Maghrabi J,Brennan S,et al.Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis.Blood,2001,97:3581-3588.
  • 5Huntly B J,Bench A,Delabesse E,et al.Derivative chromosome 9deletions in chronic myeloid leukemia:poor prognosis is not associated with loss of ABL-BCR expression,elevated BCR-ABL levels or karyotypic instability.Blood,2002,99:4547-4553.
  • 6Huntly B J,Guilhot F,Reid AG,et al.Imatinib improves but may not fully reverse the poor prognosis of CML patients with derivative chromosome 9 deletions.Blood,2003,102:2205-2212.
  • 7Quintas-Cardama A,Kantarjian H,Talpaz M,et al.Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia.Blood ,2005,105:2281-2286.
  • 8Lundan T,Volin L,Ruutu T,et al.Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9.Leukemia,2005,19:138-140.

共引文献11

同被引文献13

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部